首页> 外文期刊>BMC Cancer >A case report of primary unilateral adrenal NK/T cell lymphoma: good clinical outcome with trimodality treatment
【24h】

A case report of primary unilateral adrenal NK/T cell lymphoma: good clinical outcome with trimodality treatment

机译:一例原发性单侧肾上腺NK / T细胞淋巴瘤的病例报告:三联疗法治疗临床效果良好

获取原文
       

摘要

Background Primary natural killer (NK)/T cell lymphoma of adrenal glands is an extremely rare tumor with aggressive clinical behavior. There have only been a few cases reported worldwide and the highest reported survival was 90?days. We report the first case of primary unilateral adrenal NK/T cell lymphoma in China with good outcome. Case presentation This is a 28-year-old man who presented with abdominal pain and was found to have a large mass on the left adrenal and the top of the renal region. The patient underwent surgical resection and the pathology revealed primary adrenal NK/T cell lymphoma. He received adjuvant sandwich therapy encompassing sequential chemotherapy, radiotherapy and chemotherapy. The patient remains clinically and symptomatically disease-free with over two years follow up. Conclusion Given the rarity of this disease, there is limited experience with regard to its diagnosis and treatment. This case report will add to the scant literature on this tumor and will be useful for the differential diagnosis and treatment of adrenal disease.
机译:背景肾上腺原发性自然杀伤(NK)/ T细胞淋巴瘤是一种极为罕见的具有侵袭性临床行为的肿瘤。世界范围内只有少数病例报道,最高报道的存活时间为90天。我们报告了中国首例原发性单侧肾上腺NK / T细胞淋巴瘤的预后。病例介绍这是一个28岁的男人,有腹部疼痛,被发现在左肾上腺和肾区域的顶部有大量肿块。患者接受了手术切除,病理显示为原发性肾上腺NK / T细胞淋巴瘤。他接受了辅助三明治疗法,包括序贯化疗,放疗和化疗。经过两年多的随访,该患者在临床和症状上均无疾病。结论鉴于这种疾病的罕见性,其诊断和治疗经验有限。该病例报告将增加有关该肿瘤的文献报道,并将有助于肾上腺疾病的鉴别诊断和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号